Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2011034 | Pharmacological Reports | 2015 | 5 Pages |
Abstract
A decrease in hippocampal glutamatergic signalling after long-term neuroleptic administration may cautiously explain the incomplete effectiveness of these drugs in the therapy of schizophrenia-related cognitive disturbances.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Marek Krzystanek, Katarzyna Bogus, Artur PaÅasz, Ewa Krzystanek, John J. Worthington, Ryszard Wiaderkiewicz,